Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZ | AZN | AMGN | GILD | VRTX |
| Company | Enzo Biochem | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3702 | 203.22 | 380.00 | 148.92 | 475.30 |
| High | 0.4000 | 203.22 | 380.00 | 148.92 | 478.85 |
| Low | 0.3138 | 200.55 | 370.82 | 146.10 | 470.43 |
| Latest | 0.3138 | 201.96 | 378.80 | 148.03 | 476.14 |
| Change | -0.0678 | +0.20 | +1.80 | +0.20 | +1.87 |
| % Change | -17.77% | +0.10% | +0.48% | +0.14% | +0.39% |
| Volume | 4,123,800 | 852,999 | 761,568 | 1,545,785 | 345,173 |
| 20-Day Average Volume | 625,155 | 2,392,562 | 2,911,206 | 7,601,133 | 1,480,861 |
| Previous Close | 0.3816 | 201.76 | 377.00 | 147.83 | 474.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3655 | 201.61 | 375.97 | 150.15 | 475.94 |
| 20-Day Raw Stochastic | 23.06% | 59.44% | 73.70% | 32.96% | 45.50% |
| 20-Day Relative Strength | 38.95 | 56.00 | 59.05 | 56.57 | 52.33 |
| Weighted Alpha | -71.03 | +38.44 | +26.96 | +35.56 | +4.39 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.32% since 04/10/25 | -1.84% since 02/25/26 | -1.54% since 02/25/26 | +0.44% since 02/25/26 | -1.27% since 02/25/26 |
| Low | 0.2860 on 04/11/25 | 197.10 on 03/03/26 | 370.82 on 03/04/26 | 143.09 on 02/26/26 | 470.42 on 03/04/26 |
| High | 0.4190 on 04/16/25 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 498.02 on 03/02/26 |
| 1-Month | |||||
| %Chg | -33.25% since 03/17/25 | +7.76% since 02/04/26 | +3.34% since 02/04/26 | +1.05% since 02/04/26 | +1.36% since 02/04/26 |
| Low | 0.2520 on 04/04/25 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 454.40 on 02/11/26 |
| High | 0.5344 on 03/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -52.09% since 01/17/25 | +12.19% since 12/04/25 | +11.25% since 12/04/25 | +20.51% since 12/04/25 | +4.27% since 12/04/25 |
| Low | 0.2520 on 04/04/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 0.6868 on 01/22/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -72.23% since 10/17/24 | +23.51% since 09/04/25 | +35.10% since 09/04/25 | +31.04% since 09/04/25 | +20.15% since 09/04/25 |
| Low | 0.2520 on 04/04/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.1900 on 10/30/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,444 | 312,911,168 | 203,228,640 | 183,519,280 | 120,480,704 |
| Shares Outstanding, K | 52,403 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 31,910,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -26,080,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 7,330,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -1,540,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.19 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 03/17/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 06/12/25 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | 0.100 on 11/15/24 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | 11/15/24 | 02/20/26 | 02/13/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.24 | 17.65 | 18.41 | 29.60 |